Bovine Respiratory Disease Treatment: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024

  • ID: 4576934
  • Report
  • Region: Global
  • 100 pages
  • Infinium Global Research
1 of 4

FEATURED COMPANIES

  • Bayer AG
  • Bimeda Animal Health
  • Boehringer Ingelheim GmbH
  • Elanco
  • Merial
  • Vetoquinol
  • MORE
The report on global bovine respiratory disease treatment provides qualitative and quantitative analysis for the period of 2016 to 2024. The report predicts the global bovine respiratory disease treatment to grow with a CAGR of 6.60% over the forecast period of 2018-2024. The study on bovine respiratory disease treatment covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific and RoW for the period of 2016 to 2024.

Bovine respiratory disease is a commonly occurring respiratory disorder among cattle that may result from a single or a number of factors combined. It is usually caused by a combination of stress and disease causing agents that includes viruses and bacteria. The factors responsible for driving the growth of bovine respiratory disease treatment includes development of novel products and increase in preventive measures against bovine respiratory disease. Furthermore, increase in cattle population across the globe to meet the growing demand of meat consumption.

This increase in cattle population is likely to increase chances of bovine respiratory disease among cattle that may facilitate growth in bovine respiratory disease treatment market. However, less awareness about the bovine respiratory disease and its treatment, particularly in developing and underdeveloped regions are some of the restraints that is likely to hinder the growth in the bovine respiratory disease treatment market. Furthermore, advancement of vaccines to treat BRD is likely to boost the bovine respiratory disease market.

Among the regions, North America is expected to dominate the bovine respiratory disease treatment market in 2017, followed by Europe. U.S is responsible for driving the North America region owing to increase awareness about the disease and its treatment, high consumption of beef among its citizen, export of beef and presence of companies responsible for manufacturing vaccines for BRD. Asia Pacific is expected to grow at the highest CAGR during the forecast period owing to rising awareness about BRD disease and its treatment.

The report on bovine respiratory disease treatment is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global bovine respiratory disease treatment over the period of 2016 to 2024. Moreover, the report is collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global bovine respiratory disease treatment over the period of 2016 to 2024. Further, Growth Matrix given in the report brings an insight on the investment areas that existing or new market players can consider.

Research Methodology

Primary Research

Primary research involves extensive interviews and analysis of the opinions provided by the primary respondents.

The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached through:

1. Key Opinion Leaders associated with the author
2. Internal and External subject matter experts
3. Professionals and participants from LinkedIn, Hoovers, Factiva and Bloggers

Primary research respondents typically include:
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/country managers
5. Vice President level executives.

Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

Secondary sources of the data typically include:
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segments Covered

The global bovine respiratory disease treatment is segmented on the basis of disease type, treatment type and distribution channel.

Global Bovine Respiratory Disease Treatment by Disease Type
  • Pneumonia
  • Upper Respiratory Tract Infections
  • Diphtheria
Global Bovine Respiratory Disease Treatment by Treatment Type
  • Vaccines
  • Antibiotics
  • Immunomodulators
  • Others
Global Bovine Respiratory Disease Treatment by Distribution Channel
  • Hospitals
  • Clinics
  • Research Institutions
  • Others
Company Profiles
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Bimeda Animal Health
  • Elanco
  • Vetoquinol
  • Merial
  • Zoetis Services LLC
  • Virbac Group
How this report delivers?

1. Comprehensive analysis of global as well as regional markets of bovine respiratory disease treatment.

2. Complete coverage of all the segments in bovine respiratory disease treatment to analyze the trends, developments in the global market and forecast of market size up to 2024.

3. Comprehensive analysis of the companies operating in global bovine respiratory disease treatment. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.

4. Growth Matrix presents analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Bayer AG
  • Bimeda Animal Health
  • Boehringer Ingelheim GmbH
  • Elanco
  • Merial
  • Vetoquinol
  • MORE
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary

3. Global Bovine Respiratory Disease Treatment Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.5. Competitive Landscape in the Global Bovine Respiratory Disease Treatment

4. Global Bovine Respiratory Disease Treatment by Disease Type
4.1. Pneumonia
4.2. Upper Respiratory Tract Infections
4.3. Diphtheria

5. Global Bovine Respiratory Disease Treatment by Treatment Type
5.1. Vaccines
5.2. Antibiotics
5.3. Immunomodulators
5.4. Others

6. Global Bovine Respiratory Disease Treatment by Distribution Channel
6.1. Hospitals
6.2. Clinics
6.3. Research Institutions
6.4. Others

7. Global Bovine Respiratory Disease Treatment by Region 2018-2024
7.1. North America
7.1.1. North America Bovine Respiratory Disease Treatment by Disease Type
7.1.2. North America Bovine Respiratory Disease Treatment by Treatment Type
7.1.3. North America Bovine Respiratory Disease Treatment by Distribution Channel
7.1.4. North America Bovine Respiratory Disease Treatment by Country
7.2. Europe
7.2.1. Europe Bovine Respiratory Disease Treatment by Disease Type
7.2.2. Europe Bovine Respiratory Disease Treatment by Treatment Type
7.2.3. Europe Bovine Respiratory Disease Treatment by Distribution Channel
7.2.4. Europe Bovine Respiratory Disease Treatment by Country
7.3. Asia-Pacific
7.3.1. Asia-Pacific Bovine Respiratory Disease Treatment by Disease Type
7.3.2. Asia-Pacific Bovine Respiratory Disease Treatment by Treatment Type
7.3.3. Asia-Pacific Bovine Respiratory Disease Treatment by Distribution Channel
7.3.4. Asia-Pacific Bovine Respiratory Disease Treatment by Country
7.4. RoW
7.4.1. RoW Bovine Respiratory Disease Treatment by Disease Type
7.4.2. RoW Bovine Respiratory Disease Treatment by Treatment Type
7.4.3. RoW Bovine Respiratory Disease Treatment by Distribution Channel
7.4.4. RoW Bovine Respiratory Disease Treatment by Sub-region

8. Company Covered
8.1. Bayer Ag
8.2. Boehringer Ingelheim Gmbh
8.3. Bimeda Animal Health
8.4. Elanco
8.5. Vetoquinol
8.6. Merial
8.7. Zoetis Services LLC.
8.8. Virbac Group
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Bimeda Animal Health
  • Elanco
  • Vetoquinol
  • Merial
  • Zoetis Services LLC
  • Virbac Group
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll